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Phage Biocontrol of Campylobacter
jejuni in Chickens Does Not Produce
Collateral Effects on the Gut
Microbiota
Philip J. Richards, Phillippa L. Connerton and Ian F. Connerton*
Division of Food Sciences, School of Biosciences, University of Nottingham, Loughborough, United Kingdom
Bacteriophage biocontrol to reduce Campylobacter jejuni levels in chickens can reduce
human exposure and disease acquired through the consumption of contaminated
poultry products. Investigating changes in the chicken microbiota during phage
treatment has not previously been undertaken but is crucial to understanding the
system-wide effects of such treatments to establish a sustainable application. A phage
cocktail containing two virulent Campylobacter phages was used to treat broiler
chickens colonized with C. jejuni HPC5. Campylobacter counts from cecal contents
were significantly reduced throughout the experimental period but were most effective
2 days post-treatment showing a reduction of 2.4 log10 CFU g−1 relative to mock-
treated Campylobacter colonized controls. The administered phages replicated in vivo
to establish stable populations. Bacteriophage predation of C. jejuni was not found to
affect the microbiota structure but selectively reduced the relative abundance of C. jejuni
without affecting other bacteria.
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INTRODUCTION
Campylobacter ssp. cause foodborne illness worldwide (Kaakoush et al., 2015) and represent the
most commonly reported zoonotic pathogens in the European Union with 246,307 confirmed cases
of gastrointestinal illness in 2016 (European Food Safety Authority [EFSA], 2017). Campylobacter
jejuni is the most common species causing human disease (83.6%), but the burden of disease caused
by Campylobacter coli is also significant (8.5%) (European Food Safety Authority [EFSA], 2017).
Both species readily colonize the poultry gut, where the impact on flock health and production
parameters varies with husbandry practice and the colonizing organism (Gormley et al., 2014;
Humphrey et al., 2015). Estimates of broiler chicken flock prevalence vary between nations with
0.6 to 13.1% in the Nordic countries up to 74.2–80% in other European countries (European
Food Safety Authority [EFSA], 2010a). Source attribution studies have predicted that up to 80%
of human illness is as a result of exposure to campylobacter arising from poultry sources (European
Food Safety Authority [EFSA], 2010b). A recent source attribution study referenced at the point of
exposure confirmed chicken meat as the most important source of Campylobacter enteric disease,
with an estimated 65–69% of human campylobacteriosis cases (Ravel et al., 2017). Poultry meat
contaminated with digesta during slaughter/processing therefore represents a significant risk to
public health (Osimani et al., 2017).
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Strict on-farm biosecurity measures to mitigate the
Campylobacter colonization of poultry have been implemented in
many countries, but these alone do not eliminate campylobacter
from poultry. Additional to these efforts, intervention strategies
have been developed to reduce the Campylobacter colonization
levels of poultry, which have the potential to reduce human
exposure if the reductions can be realized on poultry meat
(Rosenquist et al., 2003; Newell et al., 2011). The use of
Campylobacter-specific bacteriophages (commonly referred to
as phages) to reduce the intestinal carriage of Campylobacter by
broiler chickens is one such intervention that has shown promise
in controlled trials (Loc Carrillo et al., 2005; Wagenaar et al.,
2005; El-Shibiny et al., 2009) and in broiler house applications
(Kittler et al., 2013). These studies have been conducted with
phage applications of one or more phage to achieve reductions
in the cecal counts of Campylobacter colonized chickens
of approximately 2 log10 CFU g−1 (Carvalho et al., 2010;
Connerton et al., 2011; Hammerl et al., 2014).
The use of multiple types of phage targeting different
receptors in the form of phage cocktails offers the prospect of
expanding the host range of the preparation whilst limiting the
potential to develop resistance to all components of the cocktail
(Chan et al., 2013). This has been explored experimentally using
Campylobacter-specific phage cocktails containing either four
(Fischer et al., 2013) or two phages (Hammerl et al., 2014). In
both cases phages were selected from both Group II and Group
III as classified by Sails et al. (1998). The classification was
originally based on total genome size and morphology but it is
now known that the two groups share little DNA similarity and
generally have different host specificities (Javed et al., 2014; Jäckel
et al., 2017). Group II and III Campylobacter bacteriophages are
taxonomically classified as members of the Myoviridae subfamily
Eucampyvirinae, which do not possess the genes required to form
stable lysogens and therefore exhibit a lytic or virulent life cycle
similar to most Myoviruses (Javed et al., 2014). Campylobacter
phage isolated using C. jejuni and C. coli hosts may show some
cross-species specificity within strains of C. jejuni and C. coli
species but have not been demonstrated to infect other species
in the Campylobacter genus, for example C. lari, C. upsaliensis,
C. fetus, C. Sputorum, or C. intestinalis (Loc Carrillo et al., 2007).
Neither have they been found to infect Helicobacter pylori,
Arcobacter butzleri, Citrobacter freundii, Salmonella enteritica
serovar Enteritidis, Escherichia coli, and Pseudomonas aeruginosa
(Loc Carrillo et al., 2007). Therefore it may be anticipated that
components of a Campylobacter phage cocktail would retain
their specificity and not give rise to dysbiosis – a detrimental
microbiota constitution that often arises post broad-spectrum
antibiotic therapies (Dethlefsen et al., 2008). However, a recent
study has suggested that exposure of the rat gut microbiome
to a cocktail of commercial phage preparations active against
Salmonella enterica, Staphylococcus aureus, Streptococcus
pyogenes, Proteus mirabilis, P. vulgaris, Pseudomonas aeruginosa,
Klebsiella pneumoniae, and E. coli results in dysbiosis with
increased inflammation and gut permeability (Tetz et al., 2017).
Bacteriophage mediated cell lysis has the potential to release
lipopolysaccharides (endotoxin) from Gram-negative bacterial
species that are potent inducers of proinflammatory cytokines
in animals and in humans (Medzhitov, 2007). Exposure to a
phage cocktail targeting multiple Gram-negative species may
well elicit such a response, although it is reported that targeted
virulent E. coli bacteriophages release less endotoxin than
β-lactam antibiotics (Dufour et al., 2017), and that the phage
tail adhesin protein Gp12 can bind free lipopolysaccharide
to counteract the inflammatory effect (Miernikiewicz et al.,
2016). Typically the lipopolysaccharides of Gram-negative
bacteria are composed of an outer membrane anchored lipid A
substituted with a core polysaccharide structure attached to a set
of repeating O-chain subunits. However, C. jejuni synthesizes
a core oligosaccharide without the repeating O-chain, which is
referred to as lipooligosaccharide (Karlyshev et al., 2005).
In this study we demonstrate that Campylobacter phage
affect the target host bacteria without provoking intestinal
dysbiosis, when phages are administered to broiler chickens at
therapeutic doses.
METHODOLOGY
Bacterial Strains and Growth Media
Campylobacter were isolated and enumerated by direct
plating on modified Cefoperazone Charcoal Deoxycholate
Agar (mCCDA) selective medium (Oxoid, Basingstoke,
United Kingdom) with addition of cefoperazone and
amphotericin B selective supplement (Oxoid) using standard
techniques. C. jejuni HPC5 was isolated from the cecal content
of a commercial broiler chicken in the United Kingdom
(Loc Carrillo et al., 2005; NCBI accession CP032316). The
universal bacteriophage host strain C. jejuni PT14 was used
to propagate Campylobacter bacteriophages (Brathwaite et al.,
2013; NCBI accession CP003871). C. coli NCTC 12668 was used
to discriminate group II and III bacteriophages (Frost et al.,
1999). C. jejuni HPC5 for the inoculation of broiler chickens
and campylobacter for the production of bacterial lawns were
cultured on horse blood agar (Blood agar base No 2; Oxoid)
with addition of plus 5% (v/v) defibrinated horse blood, (TCS,
Buckingham, United Kingdom) under microaerobic conditions
(5% O2, 5% H2, 10% CO2, 80% N2, produced by the evacuation
and replacement technique) at 42◦C for 24 h.
Bacteriophages and Propagation
Campylobacter-specific bacteriophages CP20 and CP30A were
isolated from commercial broiler chicken excreta collected in
the United Kingdom in 2001. Bacteriophages were isolated by
making a 10% suspension of excreta in SM buffer (50 mM
Tris–HCl, pH 7.5, 0.1 M NaCl, 8 mM MgSO4.7H2O, and
0.01% gelatin; Sigma Aldrich, Gillingham, United Kingdom).
This was incubated at 4◦C with agitation, for 24 h followed
by centrifugation at 13,000 × g for 5 min to remove bacteria.
The resulting supernatant was filtered through a 0.2 µm filter
(Minisart, Sartorius, Goettingen, Germany) to remove any
remaining bacteria.
When screening for the presence or absence of bacteriophage,
10 µl filtrate aliquots were applied to bacterial lawns of
C. jejuni PT14 prepared using the soft agar overlay method
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as previously described (Connerton et al., 2004). Bacteriophage
were propagated by complete plate lysis and recovered in SM
buffer before filtration (0.2 µm filter) and concentration by
centrifugation at 37,000× g.
CP20 (NCBI nucleotide accession MK408758) corresponds
to a group II Campylobacter bacteriophage and CP30A
(NCBI nucleotide accession JX569801) a group III based on
genome sizes, capsid morphologies determined by transmission
electron microscopy and genomic DNA sequences (Scott
et al., 2007a; Siringan et al., 2011, 2014; Javed et al., 2014;
Brathwaite et al., 2015).
Experimental Birds
Commercial Campylobacter-free male Ross 308 broiler
chicks were obtained as hatchlings (PD Hook, Oxfordshire,
United Kingdom). Birds were housed in a controlled
environment in individual pens under strict conditions of
biosecurity. Temperatures were as outlined in the Code of
Practice for the Housing and Care of Animals Bred, Supplied
or Used for Scientific Purposes. Birds were provided with
commercial broiler diets (starter, grower, and finisher) and
water ad libitum for the duration. The birds were weighed
and randomly assigned to 3 groups at 14 days of age. These
were: Control group consisting of Campylobacter-free sentinel
birds, Group Cj_phg, consisting of Campylobacter infected birds
to be administered with phage and Group Cj, consisting of
Campylobacter infected birds to be administered with placebo
instead of phage (mock treatment). Cloacal swabs were taken
on day 14 and tested for Salmonella by direct plating on
Xylose-Lysine desoxycholoate agar (XLD) agar (Oxoid) and
for Campylobacter by direct plating on mCCDA agar. Excreta
samples, from the same day, were tested for Campylobacter
phage (see below) and for Salmonella by enrichment in
Rappaport-Vassiliadis soya peptone broth (Oxoid) then plating
on Xylose-Lysine desoxycholoate agar (XLD) agar (Oxoid).
C. jejuni HPC5 has previously been demonstrated to establish
intestinal colonization of Ross 308 broiler chickens at 20 days
of age within 48 h of oral gavage, and to maintain colonization
levels without significant differences in cecal counts over 15 days
(Loc Carrillo et al., 2005; Connerton et al., 2018). Four days
post oral gavage was selected for phage administration to ensure
intestinal colonization, and that any variation in the cecal counts
would be evident over the period of the experiment. Birds from
Cj and Cj_phg groups were colonized with C. jejuni HPC5 at
20 days of age. Each bird received 7 log10 CFU C. jejuni in
1 ml of PBS (phosphate buffered saline) by oral gavage. Phages
were administered to Group Cj_phg as a single dose of log10
7 PFU of CP20 and CP30A combined in 1 ml of 30% CaCO3
(antacid) by oral gavage at 24 days of age. Group Cj were
administered with 1 ml of 30% CaCO3 as a placebo at 24 days
of age. Five birds were sacrificed at 24 h intervals from 25 to
29 days of age following administration of phage or placebo.
The ceca, ileum, and colon of the birds were first separated by
ligature and then removed by sterile dissection. The luminal
contents were collected for Campylobacter and bacteriophage
isolation as described below and aliquots stored at −80◦C
for DNA extraction.
Enumeration of Campylobacters
Serial dilutions of digesta were made in maximum recovery
diluent (MRD; Oxoid) and enumerated using the Miles and
Misera technique on mCCDA agar with 2% (w/v) additional agar
to reduce swarming. Plates were incubated under microaerobic
conditions at 42◦C for 48 h before typical Campylobacter
colonies were counted.
Enumeration of Bacteriophages
Bacteriophages were recovered by making a 10% suspension of
chicken digesta in SM buffer as described above. To enumerate
bacteriophage CP20 and CP30A in the phage treated groups,
independent lawns of C. jejuni HPC5 and C. coli NCTC 12668
were prepared. The C. coli strain NCTC 12668 was used as a
second host because it was sensitive to CP20 but not CP30A,
which allowed discrimination of the two phages administered.
The CP30A titers were obtained by subtraction of the CP20 titer
on C. coli 12668, from the total phage count on the C. jejuni
HPC5 host, which was sensitive to both phages. Serial dilutions
of intestinal contents were prepared in SM buffer and applied
to these lawns as 10 µl spots in triplicate. The plates were then
incubated for 24 h at 42◦C under microaerobic conditions.
Acquisition of Bacteriophage Resistance
In order to establish the frequency of resistance to bacteriophages
post-intervention, single colonies were lifted from the primary
isolation plates onto which cecal content from all phage-treated
and mock-treated control birds had been inoculated. Three
colonies per cecal sample were picked for each phage-treated
bird and subcultured on horse blood agar plates. Bacterial lawns
were prepared from successful subcultures and CP20 and CP30A
phage were applied at a range of dilutions from 1 to 3 log10 PFU
to establish if resistance had been acquired with respect to the
efficiency of plating.
DNA Isolation
DNA was isolated from both ileal and cecal content using
the Mobio PowerSoil kit (now QIAGEN Ltd., Manchester,
United Kingdom). The method used is as described in the Human
Microbiome Project SOP for processing of stool Specimens (see
Manual of Procedures for Human Microbiome v12, section
7.7 onward1.
Microbiome Analysis
The V4 regions of the bacterial 16S rRNA genes
were PCR amplified using the primers 515f (5′
GTGCCAGCMGCCGCGGTAA 3′) and 806r (5′ GGAC
TACHVGGGTWTCTAAT 3′) (Caporaso et al., 2011). Amplicons
were then sequenced on the Illumina MiSeq platform using
2 × 250 bp cycles. The 16S rRNA gene sequences were quality
filtered and clustered into operational taxonomic units (OTUs)
in Mothur (Schloss et al., 2009) using the Schloss lab. MiSeq
SOP2 (Kozich et al., 2013). Batch files of Mothur commands used
1http://hmpdacc.org/resources/tools_protocols.php
2https://www.mothur.org/wiki/MiSeq_SOP, (accessed 2018-10-05).
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FIGURE 1 | Campylobacter jejuni levels are reduced by phage predation post-treatment. Independently housed Ross 308 broilers were given 7 log10 CFU C. jejuni
by oral gavage at 20 days-old. At 24 days-old birds were orally administered a mixture of two phage at 7 log10 PFU each or a placebo of carrier alone. Five chickens
from each group were sacrificed on each day from 25 to 29 days-old, from which C. jejuni were enumerated from the intestinal contents of the ceca (A), ileum (D),
and colon (E). Titers of phage CP20 (B) and CP30A (C) were determined from cecal content. Filled squares indicate means. Error bars indicate standard deviation.
Asterix indicate statistical significance: ∗, p ≤ 0.05; ∗∗p ≤ 0.01; ∗∗∗p ≤ 0.001.
in this study are available at: https://github.com/PJRichards.
Post-processing rarefaction curves were plotted to assess
sampling effort (Supplementary Figures S1–S3). Based on these
observations the Day 1 (1dpt) ileum communities and two
further ileum communities (Group Cj: Day 2 replicate 2; Group
Cj_phg: day 4 replicate 4) were judged as having insufficient
depth, and were therefore excluded from the analysis. No
template controls were included in the analysis.
Raw sequence data are deposited in the NCBI database within
the Bioproject PRJNA506577 under the SRA study SRP170194.
Ethics Statement
All experimental animal work was performed in accordance with
United Kingdom and EU law. This study was approved by the
Local Ethics Committee of the University of Nottingham and
performed under Home Office license.
Statistical Analysis
The article was written in R 3.5.1 (R Core Team, 2018) and
Rmarkdown 1.10.8 (Allaire et al., 2018; Xie et al., 2018) using
Rstudio 1.1.456 (RStudio Team, 2015). R code used to make the
figures/tables presented here are available at: https://github.com/
PJRichards/Richards_phage_microbiota. Figure 3 was drawn in
R using code adapted from Torondel et al. (2016) and kindly
made available at: http://userweb.eng.gla.ac.uk/umer.ijaz. OTUs
discriminatory between communities were identified using LEfSE
(Segata et al., 2011). Commonality of 16S rDNA sequences
of OTUs discriminative of phage-treated (Group Cj_phg) and
untreated birds (Group Cj) with other trials performed in our
laboratory were determined using stand-alone ncbi-blast-2.7.1+
(Zhang et al., 2000)3.
RESULTS
Dual Campylobacter Bacteriophage
Treatment of Reduces Levels of
Campylobacter jejuni Colonization
Campylobacter were enumerated using standard culture methods
from intestinal luminal contents collected from the ileum, ceca,
and colon of all birds. High levels of Campylobacter were
recovered from all digesta collected from C. jejuni colonized
birds (Group Cj) throughout the 5-day period of the experiment
(mean log10 CFU g−1: ileum 6.289, ceca 8.000, colon 7.452 for
n = 25). A control group comprising of a cohort of non-colonized
sentinel birds confirmed the effectiveness of the biosecurity
measures adopted as they remained free of Campylobacter and
phage contamination.
Co-administration of a single phage dose containing CP20 (7
log10 PFU) and CP30A (7 log10 PFU) 4 days after Campylobacter
exposure at 24 days of age, significantly reduced C. jejuni
numbers in the ceca of phage-treated birds (Group Cj_phg)
compared to mock-treated birds throughout the period of the
experiment (p ≤ 0.032; Figure 1A). The phages were most
effective 2 days post-treatment (dpt), resulting in a reduction
in C. jejuni numbers of 2.365 log10 CFU g−1 in Group
Cj_phg compared to C. jejuni colonized controls in Group Cj.
3https://ftp.ncbi.nlm.nih.gov/blast/executables/LATEST/
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After this time, the numbers of C. jejuni in Group Cj_phg
birds increased but remained significantly lower than the levels
observed from mock-treated birds (Group Cj) by 1.321 log10 CFU
g−1 after 5 days.
Phage treatment was most effective in the cecum, the organ
that represents the greatest biomass of digesta and reservoir
of C. jejuni. However, treatment was also effective in reducing
C. jejuni in the ileum (p = 0.044 and 0.008 at 2 and 3
dpt, respectively) and the colon at all days excluding 2 dpt
(p ≤ 0.041; Figure 1E). The reductions in Campylobacter counts
were not as great as those observed for the ceca, with a
maximum reduction in the ileum of 1.359 log10 CFU g−1 at
3 dpt and a maximum reduction in the colon of 1.740 log10
CFU g−1 also at 3 dpt (Figures 1D,E). Bacteriophages were
enumerated over the 5 day trial period and were detected
in the cecal contents of all 5 birds treated in Group Cj_phg
from 24 h after administration (Figures 1B,C). The CP20
phage titre recovered from cecal contents of the treated birds
remained stable over time (mean 5.738 log10 PFU g−1; SD
0.460; Figure 1B), confirming that the phage were replicating
in vivo. Similarly, the mean CP30A titre was 5.708 log10 PFU
g−1 (SD 0.517; Figure 1C) confirming the two phages co-exist
without competitive exclusion. The levels of phages recovered
from ileum and colon contents also remained stable over the
course of the experiment (Supplementary Figure S4).
Bacteriophage Resistance Post
Treatment
The overall levels of phage resistance (isolates resistant to one
or both phage) in C. jejuni HPC5 isolates in Group Cj_phg was
approximately 10% (n = 7/67) of the strains recovered post-
treatment. Of these, three (4.5%) were resistant to both CP20 and
CP30A phages whilst one (1.5 %) was resistant to CP20 but not
CP30A and three (4.5%) were resistant to CP30A only. No phage
resistance was detected in the C. jejuni recovered from birds that
had not received phage (n = 32).
Bacteriophage Predation of
Campylobacter jejuni Does Not Affect
Microbiota Structure
The α-diversity (inverse Simpson index) of the cecal or ileal
microbiota of bacteriophage-treated birds (Group Cj_phg) were
not significantly different to those from mock-treated birds
(Group Cj) (p ≥ 0.095 and ≥0.841, respectively; Figures 2A,C).
There was no difference in the richness (Chao) of the cecal
FIGURE 2 | Bacterial diversity within the gastrointestinal tract is not affected by phage treatment. Box-and-whisker plot describing bacterial 16S rDNA gene content
surveys of cecal lumen contents from phage-treated (Cj_phg) or mock-untreated (Cj) groups in terms of α-diversity (inverse Simpson’s index; (A) and richness (Chao
index; (B). Corresponding α-diversity and richness for ileal lumen contents are shown in panels (C,D), respectively. Asterix indicate statistical significance: ∗p ≤ 0.05.
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microbiota between 1 and 4 dpt (p ≥ 0.151) or the ileum
microbiota at any time (p ≥ 0.548; Figures 2B,D). The Chao-
richness of the cecal microbiota of bacteriophage-treated birds
(Group Cj_phg) was significantly different from mock-treated
birds (Group Cj) by 5 dpt (p = 0.032; Figure 2B).
Exposure to Campylobacter-Phage
Selectively Reduces Proportions of
C. jejuni Without Affecting the Wider
Microbiota
Throughout the experiment the predominant bacterial
phylum present in the ileal lumen was the Firmicutes
with a median relative abundance (RA) of 83.091%
(Supplementary Figure S5A). There were no differences
in relative abundance between age-matched bacteriophage-
treated (Group Cj_phg) and mock-treated birds (Group Cj)
in this phylum (p ≥ 0.063, Wilcoxon test; Supplementary
Figure S5A). The next most abundant phylum are the
Proteobacteria where a difference at 4 dpt was observed
(p = 0.016), but not on any other day (p ≥ 0.730, Wilcoxon test;
Supplementary Figure S5A). Phyla-level composition of the
cecal microbiotas of both groups were likewise dominated by
Firmicutes (median 90.620% RA), and to a much lesser extent
Proteobacteria (4.747% RA) (Supplementary Figure S5B).
However, there was no difference in the relative abundance of
Firmicutes or Proteobacteria between phage-treated (Group
Cj_phg) and mock-treated birds (Group Cj) at any time
post-treatment (p ≥ 0.178, t-test; and p ≥ 0.151, Wilcoxon
test; respectively).
At the OTU level, phage treatment did not affect the
β-diversity (Bray Curtis distance) between communities of ileal
lumen bacteria from age-matched phage-treated (Group Cj_phg)
and mock-treated birds (Group Cj) at any time point (p = 0.106;
AMOVA; Supplementary Figure S6A). The 11 most abundant
OTUs in the ileum lumen are shown in Figure 3A. After the
OTUs were filtered to include only those ≥1% of total reads,
the only discriminative OTU between phage-treated and mock-
treated birds identified using LEfSE (Segata et al., 2011) was
OTU0013 [Campylobacter (100)] at 3 dpt (p = 0.009).
The 11 most abundant OTUs in the cecal lumen are
shown in Figure 3B. For populations of cecal bacteria
the β-diversity was not different at 1 to 4 dpt (p ≥ 0.088,
Supplementary Figure S6B). However, bacterial populations
could be distinguished at 5 dpt (p = 0.021). At 5 dpt OTU0009
[Clostridiales_unclassified (100)] was the sole discriminative
OTU between the treatments (p = 0.027; LEfSE; Supplementary
Figure S7D), which was present in significantly greater
proportions in the mock-treated birds (Group Cj) relative
to phage-treated birds (Group Cj_phg) (mean % RA = 1.211
and 6.668, respectively) (Figure 3A). Previous work from
our laboratory identified an OTU with 100% DNA sequence
FIGURE 3 | Bacteriophage treatment reproducibly only affects C. jejuni proportions. Stacked bar charts showing bacterial community compositions from the ileum
(A) and ceca (B) of all birds. For clarity only the 11 most abundant OTUs are described with all other OTUs summarized as “other.”
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identity to OTU0009 as being associated with Campylobacter-
colonized birds [see OTU0073 in Connerton et al. (2018)].
Discriminative analysis of the cecal communities associated
a greater abundance of Camplylobacter (OTU0013) with the
mock-treated birds (Group Cj) at 3 and 4 dpi (p < 0.047;
Supplementary Figures S7B,C, respectively). A positive
association was observed between phage-treated (Cj_phg) birds
at 1 dpt and OTUs 0006 and 0021, representing Clostridium IV
(98) and Clostridiales_unclassified (100), respectively (p = 0.047;
Supplementary Figure S7A and Figure 3B).
At 5 dpt the bacterial communities of the ceca or ileum
of Campylobacter-free sentinel control birds could not be
distinguished from mock-treated Campylobacter-colonized birds
(Group Cj, p > 0.05; Supplementary Figures S6A,B), but
cecal populations of bacteria in the phage-treated birds (Group
Cj_phg) could be distinguished from non-colonized control birds
(p = 0.014). Correspondingly, the OTUs that are associated
with phage-treated treated birds (Group Cj_phg) are OTU0006
Clostridium IV (98) and OTU0009 Clostridiales_unclassified
(100), which were also identified as discriminating phage-
treated treated birds from mock-treated birds at 1 and 5 dpt,
respectively (Supplementary Figure S8B). Although there was
no difference in the β-diversity of non-colonized and mock-
treated colonized birds in these cohorts, as expected OTU0013,
representing Campylobacter (100), showed association with
colonized birds, but conversely OTU0031, Bifidobacterium
(100), showed association with the non-colonized control birds
(Supplementary Figure S8A). This observation is also consistent
with our previous study which demonstrates the differential
association of an OTU with 100% DNA sequence identity with
non-colonized birds compared to those 2 days post-colonization
with C. jejuni at 20 days of age (NCBI database SRA study
SRP133552; Connerton et al., 2018).
Interestingly, the low diversity of the ileal bacterial
communities, relative to the cecal microbiota (see Figures 2A,B),
is revealed in the observation that the top 11 most abundant
OTUs across all ileal communities constitute 90.754% of
reads, whereas the top 11 most abundant OTUs across
all cecal communities account for a lower quotient of
48.670% reads (Figures 3A,B). We note that ileal samples
showed some similarity to no template controls at phyla
level (Supplementary Table 1), and that there was notable
correspondence in the γ-proteobacteria [Escherichia/Shigella
(100)] among the top 11 most abundant OTUs from ileal and
cecal samples and the most abundant kitome/contaminant OTUs
(Figures 3A,B; Supplementary Table 2).
DISCUSSION
The results described here provide further evidence of the efficacy
of phage treatment to reduce the Campylobacter colonization
of chickens. It has been widely suggested that an advantage of
phage biocontrol over antibiotic use or other broad-spectrum
types of therapy against pathogens that inhabit the intestinal tract,
is the specificity of the bacteriophage selected for a particular host
(Sulakvelidze and Barrow, 2004; Sulakvelidze and Kutter, 2004).
This specificity is presumed to avoid the possibility of causing
dysbiosis but recently this assumption has been challenged
using a multi-phage treatment to affect collateral changes in
the composition of the microbiota of rats with decreases in
the abundance of Blautia, Catenibacterium, Lactobacillus, and
Faecalibacterium species, and increases in the abundance of
Butyrivibrio, Oscillospira, and Ruminococcus (Tetz et al., 2017).
This is in contrast to directed studies using simulated gut
microbial consortia (duodenum and ileum) containing a specific
Escherichia coli as a bacteriophage target, where the impact
of phage therapy was compared with ciprofloxacin treatment
(Cieplak et al., 2018). Bacteriophage and antibiotic therapies
were equally as effective in reducing the target Escherichia
coli population by 2 to 3 log10 CFU ml−1 but notably the
bacteriophage treatment had no measurable impact on non-
target bacteria.
Although Campylobacter phages selected for the biocontrol
of campylobacter in chickens appear to be confined to
replication in C. jejuni and C. coli as hosts (Loc Carrillo
et al., 2007), this discrimination had not previously been
verified from the intestinal microbiota of Campylobacter
colonized chickens. Frequency and abundance estimates
of campylobacters and phages recovered from the ceca
of commercial broiler chickens support the contention
that production birds are often exposed to phage, and
that phage presence coincides with a reduction in the
mean Campylobacter cecal counts by approximately 1.8
log10 CFU g−1 (Atterbury et al., 2005). However, this
study also demonstrated that phage which replicate on
Campylobacter could be recovered in the absence of culture
detectable Campylobacter host bacteria. The study left an
open question as to whether the presence of phage under
certain circumstances can drive Campylobacter populations
below the culture detection limit (<2 log10 CFU g−1) or
that phage infecting campylobacters could also replicate
on alternative host bacteria present in the microbiota of
chickens. Further motivation for the current study was to
establish whether phage therapy under these circumstances
constitutes a minimal targeted intervention that utilizes
biocontrol agents that are not detrimental to the intestinal
microbiota of farmed chickens, and to which consumers are
already exposed.
Phage therapy of C. jejuni colonized chickens produced
significant reductions in intestinal C. jejuni counts compared to
mock-treated controls over 5 days. However, the introduction
of the phages did not affect the structures of the cecal or
ileal microbiotas of the birds based on calculations of
α-diversity (inverse Simpson index). The richness (Chao)
of the microbiota remained similarly indistinguishable until 4
dpt. At the phyla level no difference in the abundance of the
major components were observed for the cecal microbiotas
representing the greatest biomass, and at only one time point
was any difference observed post-phage treatment for the ileal
microbiotas (4 dpt). Analysis of differences in the relative
abundance between phage-treated and mock-treated ileal and
cecal community OTUs highlights significant differences in
OTU0013 that represents the phage therapy target, C. jejuni.
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Additional to this, the cecal community member OTU0009
(Clostridiales_unclassified) showed significantly greater
proportions in the mock-treated birds relative to phage-
treated birds, as had previously been identified on the basis
of the association of a DNA sequence identical OTU with
Campylobacter-colonized birds (Connerton et al., 2018). The
consistent association could be indicative of a key reliance
for the corresponding clostridial organism(s) on high levels
of Campylobacter colonization of the chicken gut. These
observations further the idea that campylobacters can act
as a hydrogen sink to improve the growth and competitive
standing of specific clostridia (Kaakoush et al., 2015). The
Bifidobacterium OTU0031 showed association with non-
colonized sentinel birds, which is in contrast to 16S rRNA
qPCR data reported by Thibodeau et al. (2015) that showed
an increase in the molecular detection of Bifidobacterium
sp. upon C. jejuni colonization. The authors noted that
Bifidobacterium had previously been reported to hinder
C. jejuni colonization (Ding et al., 2005; Santini et al.,
2010), and that subtle effects may occur during C. jejuni
colonization of chickens.
We observed the emergence of phage resistant C. jejuni
post-phage treatment in this study as reported previously (Loc
Carrillo et al., 2005; El-Shibiny et al., 2009; Fischer et al.,
2013; Hammerl et al., 2014). We did not recover any phage
resistant C. jejuni from the non-phage treated chickens despite
the propensity of C. jejuni to undergo phase variation in
genes leading to phage resistance (Aidley et al., 2017), and
suggesting the observed phage escape mutation frequency of
10% in this experiment was a consequence of selection due
to phage predation. The observed phage resistance frequency
is within those reported previously of 1–14% (Loc Carrillo
et al., 2005; El-Shibiny et al., 2009; Carvalho et al., 2010;
Fischer et al., 2013; Hammerl et al., 2014). The phage treatment
of chickens to reduce Campylobacter colonization has been
demonstrated to be most effective over a 2–3 day period post-
treatment (Loc Carrillo et al., 2005; El-Shibiny et al., 2009),
since thereafter Campylobacter populations begin to recover.
The continued impact of Campylobacter phage predation on
the wider intestinal microbiota could not be assessed within
the treatment timeframe examined in the current experiment
(Connerton et al., 2018). However, when the time to slaughter
after phage therapy was extended, the cecal Campylobacter levels
were not reported to achieve the levels observed in non-treated
controls (Fischer et al., 2013). This is likely due to reduced
competitive fitness of the resistant types as described previously
(Loc Carrillo et al., 2005; Scott et al., 2007a,b), and supports the
supposition of Wagenaar et al. (2005) that the release of virulent
Campylobacter phages into the environment would not constitute
any greater risk.
Bacteriophage CP20 is a group II phage based on genome
size and DNA sequence similarities. Group II phage are generally
flagellotropic that require the host to be motile with a functional
flagellar (Coward et al., 2006; Scott et al., 2007a,b; Baldvinsson
et al., 2014; Lis and Connerton, 2016; Liang and Connerton,
2018). CP30A is a group III phage that in common with this
phage group exhibits dependence on capsular polysaccharide
structures (Sørensen et al., 2011; Lis and Connerton, 2016). The
post-phage treatment C. jejuni isolates we identified as resistant
to both phage classes will be of interest to examine with respect to
their ability recolonize chickens and the nature of the mutation.
Although we note they remain a minority population within the
chicken gut even in the presence of bacteriophage controlling
the wild type C. jejuni populations. These bacteria are likely at
a competitive disadvantage to the wild type.
We have rigorously examined the microbiota of
Campylobacter colonized chickens treated with either phages or
a placebo to provide strong evidence for the lack of any collateral
effect on the gut microbiome.
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FIGURE S1 | Rarefaction curves indicating coverage of Campylobacter-colonized
(experimental) cecal bacterial communities. 16S rDNA bacterial communities from:
(A) 1 day post-treatment (dpt); (B) 2 dpt; (C) 3 dpt; (D) 4 dpt; (E) 5 dpt. Cohort: (i)
Group Cj (ii) Group Cj_phg.
FIGURE S2 | Rarefaction curves indicating coverage of Campylobacter-free
non-colonized (control) cecal bacterial communities. 16S rDNA bacterial
communities from Campylobacter-free non-colonized control birds at 29 days-old,
equivalent to 5 days post-treatment.
FIGURE S3 | Rarefaction curves indicating coverage of ileal bacterial
communities. 16S rDNA bacterial community from: (A) 2 day post-treatment (dpt);
(B) 3 dpt; (C) 4 dpt; (D) 5 dpt. The non-phage treated cohort (Group Cj) are shown
in panels Ai to Di, and the phage treated cohort (Group Cj_phg) in panels Aii to Dii.
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FIGURE S4 | Campylobacter phage titers in the ileum and colon post-treatment.
Phage tiers were determined for CP20 (A) and CP30A phage (B) from ileal
content and colon content (C), CP20; (D), CP30A). Filled squares indicate mean.
Error bars indicate standard deviation.
FIGURE S5 | Stacked barchart showing phyla-level microbiota composition for
ileal and cecal communities. OTUs were filtered so that only Phyla present in more
than one ileal or cecal community are included in the analysis. Figures in
parenthesis in the key indicate bootstrap values for that taxonomic assignment
generated in Mothur. All taxa shown in the key were detected in the ileum lumen
including those of low abundance (A). However, note that only Actinobacteria,
Bacteria_unclassified, Bacteroidetes, Firmicutes, and Proteobacteria phyla were
detected in cecal communities (B).
FIGURE S6 | Relationship between communties of gut bacteria from
phage-treated and mock-treated birds. PCoA plot of Bray-Curtis distance
between A) ileal (R2 = 0.41; A,B) cecal communities (R2 = 0.75; B).
FIGURE S7 | Cecal bacterial taxa responsive to Campylobacter-phage treatment.
OTUs were filtered to only include those representing at least 1% of the total reads
before all communities were randomly subsampled an equal depth for unbiased
comparison. Discriminatory OTUs were then described between age-matched
groups using LEfSE. LDA refers to Linear Discriminant Analysis. 1 dpt (A), 3 dpt
(B), 4 dpt (C), 5 dpt (D). There were no differential OTUs at 2 dp.
FIGURE S8 | Gut bacterial taxa responsive to Campylobacter-colonization at
5 days post-treatment. OTUs were filtered as described for Supplementary
Figure S7 and discriminatory OTUs identified using LEfSE. LDA refers to Linear
Discriminant Analysis. Control-Group Cj comparison (A), Control-Group Cj_phg
comparison (B).
TABLE S1 | Description of phyla associated with no template controls. Due to
potential for low biomass and dominant contaminant profile from ileum samples
the kitome microbiota profile is included. Table text in parenthesis indicates Mothur
taxonomy bootstrap values. Samples: kitome for all samples, excluding 1 dpt (kit
Ai and kit Aii); kitome for 1 dpt (kit B); sequencing negative control for all samples,
excluding 1 dpt (seq Ai and seq Aii); sequencing negative control for 1 dpt (seq B).
TABLE S2 | Description of top 10 OTU associated with no template controls.
Table text in parenthesis indicates Mothur taxonomy bootstrap values.
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